Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy

Springer Science and Business Media LLC - Tập 7 Số 2 - Trang 152-159 - 2016
Sarah J. Valle1, Nayef Alzahrani1, Winston Liauw1, Paul H. Sugarbaker2, Aditi Bhatt3, David L. Morris1
1Department of Surgery, University of New South Wales & St George Hospital, Kogarah, Australia
2Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, DC, USA
3Department of Surgical Oncology, Fortis Hospital, Bangalore, India

Tóm tắt

Từ khóa


Tài liệu tham khảo

Elias D, Glehen O, Gilly F, et al. (2008). Carcinose peritoneles d’origine digestive et primitive. In: Rapport du 110eme congress de l’AFC. Arnette: Wolters Kluwer France.

Sugarbaker PH (2003) Peritonectomy procedures. Surg Oncol Clin N Am 12:703–727

Trimble EL, Thompson S, Christian MC, Minasian L (2008) Intraperitoneal chemotherapy for women with ovarian cancer. The Oncologist 13(4):403–409

Yan TD, Welch L, Black D, et al. (2007) A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 18:827–834

Yan TD, Black D, Savady R, (2006) et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol;24:4011–4019.

Yonemura Y, Bando E, Kawamura T, et al. (2007) Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 134:357–373

Kusamura S, Elias D, Baratti D, (2008) et al. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol;98:247–252.

Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42

De Bree E, Tsiftsis DD (2007) Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Recent Results Cancer Res 169:39–51

Elias D, Antoun S, Goharin A, (2001) et al. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig;1:431–439.

Deraco M, Glehen O, Helm CW, Morris DL, Van der Speeten K (2013) Sugarbaker PH. In: Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas. Cine-med, Canada

Van der Speeten K, Stuart OA, Caillot JL, (2011) et al. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol;68:147–156.

Elias D, Lefevre JH, Chevalier J, (2009) et al. Complete cytoreductive surgery plus intraperitoneal chemohypethermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol;27:681–685.

De Somer F, Ceelen W, Delanghe J, et al. (2008) Severe hyponatremia, hyperglycemia and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin. Perit Dial Int 28:61–66

Dedrick RL (1985) Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 12(3):1–6

Yan TD, Black D, Sugarbaker PH, et al. (2007) A systematic review and metaanalysis of the randomised controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14:2702–2713

Markman M, Bundy BN, Alberts DS, et al. (2001) Phase III trial of standard dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 19:1001–1007

Hayes-Jordan A, Owusu-Agyemang P, Green H (2012) Anaesthetic management and renal function in paediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin. Ann Surg Oncol 19:2652–2656

Glehen O, Cotte E, Kusamura S, et al. (2008) Hyperthemic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol 98:242–246

Jacquet P, Averbach A, Stephens AD, et al. (1998) Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-flurouracil: pharmacokinetic studies. Oncology 55:130–138

Glehen O, Sugarbaker PH, Elias D, et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer. A multi-institutional study. J Clin Oncol 22:3284–3292

Elias D, Benizri E, Di Pietrantonio D, et al. (2007) Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14:509–514

Sammartino P, Accarpio F, Cornal T, et al. (2015) Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) combined. In: Di Georgio A & Pinto E. Treatment of peritoneal surface malignancies: updates in surgery. Pg 107–127.

Mathe G, Kidani Y, Seglguchi M, et al. (1989) Oxalato-platinum or I-OHP, a third generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum. Biomedicine and Pharmacotherapy. 43:237–250

De Gramont A, Tournigand C, Louvet C, et al. (1997) Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX) in pretreated patients with metastatic advanced cancer the GERCOD. La Revuede Medecine Interne/Fondee Par La Societe Nationale Francaisede Medecine Interne 18:769–775

Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH (2010) Pharmacology of perioperative 5-fluorouracil. J Surg Oncol 102(7):730–735

Jacquet P, Averbach AM, Stuart OA, Chang D, Sugarbaker PH (1998) Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism and tissue distribution in a rat model. Cancer Chemother Pharmacol 41:147–154

Yonemura Y, Bandou E, Sawa T, et al. (2006) Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 32:661–665

Sugarbaker PH (1996) Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy. Cancer Treat Res 82:317–325

Zylberberg B, Dormont D, Janklewicz S, et al. (2001) Response to neoadjuvant intraperitoneal and intravenous immunochemotherapy followed by interval secondary cytoreduction in stage IIIC ovarian cancer. Eur J Gynaecol Oncol 22:40–45

Esquivel J, Vidal-Jove J, Steves MA, et al. (1993) Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 113:631–636

Jacquet P, Sugarbaker PH (1996) Peritoneal-plasma barrier. Cancer Treat Res 82:53–63

Jones RB, Myers CE, Guarino AM, et al. (1978) High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. pharmacologic basis and early results. Cancer Chemother Pharmacol 1:161–166

MacArthur KM, Nicholl MB (2013) Principles and innovations in peritoneal surface malignancy treatment. World J Oncol 4(3):129–136

Dedrick RL, Myers CE, Bungay PM, et al. (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1–11

Gonzalez-Moreno S, Gonzalez-Bayon LA, Ortega-Perez G (2010) Hyperthemic intraperitoneal chemotherapy: rationale and technique. WJGO 2(2):68–75

Pillai K, Akhter J, Chua T, Morris DL (2014) A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei. Int J Cancer 134:478–486

Speyer JL, Sugarbaker PH, Collins JM, et al. (1981) Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 41:1916–1922

Elias D, Bonnay M, Puizillou JM, et al. (2002) Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13:267–272

Sugarbaker PH, Mora JT, Carmignani P, et al. (2005) Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10:112–122

Keshaviah P, Emerson PF, Vonesh EF, et al. (1994) Relationship between body size, fill volume and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 4:1820–1826

Sticca RP, Dach BW (2003) Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am 12(3):689–701

Piche N, Leblond FA, Sideris L, et al. (2001) Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis. A study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann. Surg. 254:138–144

Leunig M, Goetz AE, Dellian M, et al. (1992) Interstitial fluid pressure in solid tumours following hyperthermia: possible correlation with therapeutic response. Cancer Res 52:487–490

Esquis P, Consolo D, Magnin G, et al. (2006) High intraabdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental carcinomatosis. Ann Surg 244:106–112

Glehen O, Osinsky D, Cotte E, et al. (2003) Intraperitoneal chemohyperthemia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–869

Yonemura Y, Fujimura T, Fushida S, et al. (1991) Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 15:530–536

Gonzalez-Bayon L, Gonzalez-Moreno S, Ortega-Perez G (2006) Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion. Eur J Surg Oncol 32:619–624

Halkia E, Tsochrinis A, Vassiliadou DT, et al. (2015) Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol 610597

Ortega-Deballon O, Facy O, Jambet S, et al. (2010) Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol 17(7):1957–1963

Stephens AD, Alderman R, Chang D, et al. (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–796

Stuart O, Stephens AD, Welch L, et al. (2002) Safety monitoring of the coliseum technique for heated intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol 9:186–191

Garofalo A, Valle M, Garcia J, et al. (2006) Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. EJSO 32:682–685

Valle M, Van der Speeten K, Garofalo A (2009) Laparoscopic hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients. J Surg Oncol 100:331–334

Valle SJ, Alzahrani N, Alzahrani S, Liauw W, Morris DL (2015) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery. Int J Surg 23:176--180

Esquivel J, Averbach A, Chua TC (2011) Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 253:764–768